Connection between sleep cycle and cancer incidence
the ONA take:
A study by Virginia Tech biologists found that the benefits of a good night’s sleep include preventing cancer. These findings are likely to provide insight into the influence of the body’s internal clock on cancer development.
The researchers found that the protein human period 2 is responsible for regulating the body’s sleep cycle, or circadian rhythm. It also protects the body from developing sporadic forms of cancer. Unaltered, the human period 2 protein interacts with tumor suppressor proteins in cells to control cell division.
When environmental factors are altered, including sleep cycle disruption, the function of the protein is impaired. The connection between the protein, circadian rhythm, and cancer development was observed by studying various human and animal tumor cells.
The researchers found that repressing the human period 2 gene led to abnormal circadian rhythmicity and a malignant transformation. Researchers have long studied the connection between circadian rhythms and cancer development, particularly breast cancer, in women who work night shifts such as nurses and flight attendants.
Researchers are now working closely with patients to identify those who may be at risk for cancer due to the malfunction of the human period 2 protein and the gene that produces it.
Benefits of a good night’s sleep include preventing cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
- Colorectal Cancer Screening Rate Increased by Digital Self-Ordering
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|